Adenosine A2 receptors stimulate c-fos expression in striatal neurons of 6-hydroxydopamine-lesioned rats

Neuroscience. 1995 Jul;67(1):49-55. doi: 10.1016/0306-4522(94)00602-2.

Abstract

The induction of the early-gene c-fos after administration of the adenosine A2a receptor agonist CGS 21680, was studied in the striatum of normal rats or in rats with a unilateral 6-hydroxydopamine lesion of the dopaminergic nigrostriatal neurons. CGS 21680 (2.25 mg/kg) induces c-fos expression in the 6-hydroxydopamine-lesioned striatum, while up to 40 mg/kg fails to induce c-fos in the intact striatum or in the striatum of normal rats. Blockade of muscarine receptors by scopolamine (5 mg/kg) partially prevents, and stimulation of dopamine D2 receptors by quinpirole (0.5 mg/kg) completely reverses, CGS 21680-induced c-fos expression in the 6-hydroxydopamine-lesioned striatum. In turn, CGS 21680 partially reverses c-fos expression induced by quinpirole in the lesioned globus pallidus. CGS 21680, in addition, dose-dependently reduces the turning behavior induced by quinpirole (0.5 mg/kg) in 6-hydroxydopamine-lesioned rats. The results suggest that CGS 21680 induces c-fos expression in the striatum through direct and indirect mechanisms related to the ability of A2a receptors to stimulate cyclic AMP formation or acetylcholine release which in turn would activate c-fos through muscarinic receptors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine / analogs & derivatives*
  • Adenosine / antagonists & inhibitors
  • Adenosine / pharmacology
  • Animals
  • Antihypertensive Agents / antagonists & inhibitors
  • Antihypertensive Agents / pharmacology*
  • Dopamine D2 Receptor Antagonists
  • Ergolines / pharmacology
  • Gene Expression / drug effects*
  • Genes, fos / drug effects*
  • Immunohistochemistry
  • Male
  • Muscarinic Antagonists / metabolism
  • Neostriatum / cytology
  • Neostriatum / drug effects
  • Neostriatum / metabolism*
  • Neurons / drug effects
  • Neurons / metabolism*
  • Oxidopamine
  • Phenethylamines / antagonists & inhibitors
  • Phenethylamines / pharmacology*
  • Purinergic P1 Receptor Agonists
  • Quinpirole
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Dopamine D2 / agonists
  • Receptors, Dopamine D2 / metabolism
  • Receptors, Purinergic P1 / metabolism*
  • Stereotyped Behavior / drug effects
  • Sympathectomy, Chemical*

Substances

  • Antihypertensive Agents
  • Dopamine D2 Receptor Antagonists
  • Ergolines
  • Muscarinic Antagonists
  • Phenethylamines
  • Purinergic P1 Receptor Agonists
  • Receptors, Dopamine D2
  • Receptors, Purinergic P1
  • 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine
  • Quinpirole
  • Oxidopamine
  • Adenosine